Olefir I. S.

DEVELOPMENT OF THE DRY EYE DISEASE AFTER COVID-19

---

Show/Download

About the author:

Olefir I. S.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

In 2019, the COVID-19 epidemic shocked the whole world and fundamentally changed the way of life mostly all people, who reduced social contacts and spent more time in front of gadget screens due to quarantine. Among the ophthalmological symptoms, the development of viral conjunctivitis, episcleritis, retinal microhemorrhages, maculopathies and optic neuritis were most often reported. These symptoms most often occurred during the coronavirus disease. However, the recovery period after a severe viral infection, according to the latest data, also has its own variants of pathological ophthalmic conditions. One of them is dry eye syndrome, which causes significant discomfort and even a decrease in work capacity and quality of life, because, unfortunately, it is not possible to recover without constant supportive therapeutic treatment. The purpose of this work was to evaluate and compare the occurrence of dry eye disease (DED) and its severity in patients with a history of SARS-CoV-2 and in patients who had no symptoms of coronavirus infection for more than 1 year. We monitored 46 patients who were divided into two groups depending on the duration of the SARS-CoV-2 infection. In patients with an early period after the transfer of COVID-19, it was found that in 78% of cases (18 of 23 patients), lacrimation, moderate photophobia, foreign body sensation and decreased visual acuity were observed. The above-mentioned complaints in the vast majority (52% of cases) occurred in women (12/23). In another cohort of patients who had symptoms of coronavirus infection more than 1 year ago, manifestations of DED were detected in only 35% of cases (8 patients out of 23 examined in this group). Therefore, when we compared the study groups according to the data of a specific examination for the presence and severity of dry eye disease and also patienst complaints, we found out that the subjects who had SARS-CoV 3-4 months before the examination were more than 2 times more likely to suffer from the manifestations of dry eyes (35 and 78%, respectively), compared to patients with a longer period after recovery.

Tags:

Bibliography:

1. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973– 1987. DOI: 10.1016/S0140-6736 (20)31142-9.
2. Naser AY, Al-Hadithi HT, Dahmash EZ, Alwafi H, Alwan SS, Abdullah ZA. The effect of the 2019 coronavirus disease outbreak on social relationships: A cross-sectional study in Jordan. Int J Soc Psychiatry. 2021;67(6):664–671.
3. Alyami HS, Naser AY, Dahmash EZ, Alyami MH, Alyami MS. Depression and anxiety during the COVID-19 pandemic in Saudi Arabia: A cross-sectional study. Int J Clin Pract. 2021;75(7):e14244.
4. Abusamak M, Jaber HM, Alrawashdeh HM. The Effect of Lockdown Due to the COVID-19 Pandemic on Digital Eye Strain Symptoms Among the General Population: A Cross-Sectional Survey. Front Public Health. 2022;10:895517.
5. Kaidashev I, Shlykova O, Izmailova O, Torubara O, Yushchenko Y, Tyshkovska T, et al. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon. 2021 Aug;7(8):e07863.
6. Regmi A, Suresh J, Asokan R. Changes in work patterns during COVID-19 lockdown and its impact on the eyes and body. Clin Exp Optom. 2023;106(3):331–337.
7. Talens-Estarelles C, García-Marqués JV, Cervino A, García-Lázaro S. Use of digital displays and ocular surface alterations: A review. Ocul Surf. 2021;19:252–265.
8. Shimazaki J, Nomura Y, Numa S, Murase Y, Kakinoki K, Abe F, et al. Prospective, multicenter, cross-sectional survey on dry eye disease in Japan. Adv Ther. 2020;37:316–328
9. Kaido M, Kawashima M, Yokoi N, Fukui M, Ichihashi Y, Kato H, et al. Advanced dry eye screening for visual display terminal workers using functional visual acuity measurement: the Moriguchi study. Br J Ophthalmol. 2015;99(11):1488–1492.
10. Craig JP, Wang MTM, Ambler A, Cheyne K, Wilson GA. Characterising the ocular surface and tear film in a population-based birth PAPAS | 13 cohort of 45-year old New Zealand men and women. Ocul Surf. 2020;18:808–813
11. Greco G, Pistilli M, Asbell PA, Maguire MG, Dry Eye Assessment and Management Study Research Group. Association of Severity of Dry Eye Disease with Work Productivity and Activity Impairment in the Dry Eye Assessment and Management Study. Ophthalmology. 2021;128(6):850–856.
12. Vehof J, Snieder H, Jansonius N, Hammond CJ. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2021;19:83–93.
13. Okumura Y, Inomata T, Iwata N, Sung J, Fujimoto K, Fujio K, et al. A Review of Dry Eye Questionnaires: Measuring Patient-Reported Outcomes and Health-Related Quality of Life. Diagnostics. 2020;10(8):559.
14. McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocular Surf. 2016;14(2):144–167.
15. Tsuber V, Kadamov Y, Tarasenko L. Activation of antioxidant defenses in whole saliva by psychosocial stress is more manifested in young women than in young men. PLoS One. 2014 Dec 19;9(12):e115048.
16. Bhattacharya S, Heidler P, Saleem SM, Marzo RR. Let There Be Light-Digital Eye Strain (DES) in Children as a Shadow Pandemic in the Era of COVID-19: A Mini Review. Front Public Health. 2022;10:945082.

Publication of the article:

«Bulletin of problems biology and medicine», 2024 Issue 1, 172, 228-231 pages, index UDC 617.711-004.1:619.9

DOI:

10.29254/2077-4214-2024-1-172-228-231